MedTrace Logo

Feasibility of Using NeuraSignal Transcranial Doppler Robot

NCT06565442 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2026-05-08

No results posted yet for this study

Summary

The purpose of this study is to determine the feasibility of using the NeuraSignal transcranial doppler robot in a neuro ICU setting to measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves

Conditions

  • Cerebral Autoregulation

Interventions

DEVICE

NeuraSignal transcranial doppler robot

measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves

Sponsors & Collaborators

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Emily A Wasson, MD,MPH · University of Alabama at Birmingham

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-15
Primary Completion
2026-12-14
Completion
2027-12-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06565442 on ClinicalTrials.gov